UK consults on GSL move for naproxen

18 February 2014 - Deborah Wilkes

Archived

Galpharm Healthcare is seeking to switch 250mg naproxen tablets for period pain from pharmacy to general-sales-list (P-to-GSL) status in the UK.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: